ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P46734


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name MP2K3_HUMAN
Primary accession number P46734
Secondary accession numbers B3KSK7 Q99441 Q9UE71 Q9UE72
Integrated into Swiss-Prot on November 1, 1995
Sequence was last modified on November 1, 2002 (Sequence version 2)
Annotations were last modified on    June 16, 2009 (Entry version 97)
Name and origin of the protein
Protein name Dual specificity mitogen-activated protein kinase kinase 3
Synonyms MAP kinase kinase 3
MAPKK 3
EC 2.7.12.2
MAPK/ERK kinase 3
Gene name
Name: MAP2K3
Synonyms: MEK3, MKK3, PRKMK3
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
TISSUE=Brain;
DOI=10.1126/science.7839144; PubMed=7839144 [NCBI, ExPASy, EBI, Israel, Japan]
Derijard B., Raingeaud J., Barrett T., Wu I.-H., Han J., Ulevitch R.J., Davis R.J.;
"Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms.";
Science 267:682-685(1995).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
DOI=10.1074/jbc.271.43.26981; PubMed=8900184 [NCBI, ExPASy, EBI, Israel, Japan]
Moriguchi T., Toyoshima F., Gotoh Y., Iwamatsu A., Irie K., Mori E., Kuroyanagi N., Hagiwara M., Matsumoto K., Nishida E.;
"Purification and identification of a major activator for p38 from osmotically shocked cells: activation of mitogen-activated protein kinase kinase 6 by osmotic shock, tumor necrosis factor-alpha, and H2O2.";
J. Biol. Chem. 271:26981-26988(1996).
[3]
NUCLEOTIDE SEQUENCE (ISOFORMS 2 AND 3).
Han J.;
Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Trachea;
DOI=10.1038/ng1285; PubMed=14702039 [NCBI, ExPASy, EBI, Israel, Japan]
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
TISSUE=Leukocyte;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
PHOSPHORYLATION AT SER-218 AND THR-222, AND MUTAGENESIS OF SER-218 AND THR-222.
PubMed=8622669 [NCBI, ExPASy, EBI, Israel, Japan]
Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J.;
"MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.";
Mol. Cell. Biol. 16:1247-1255(1996).
[7]
INTERACTION WITH DYRK1B.
TISSUE=Muscle;
DOI=10.1074/jbc.M203257200; PubMed=11980910 [NCBI, ExPASy, EBI, Israel, Japan]
Lim S., Jin K., Friedman E.;
"Mirk protein kinase is activated by MKK3 and functions as a transcriptional activator of HNF1alpha.";
J. Biol. Chem. 277:25040-25046(2002).
[8]
INTERACTION WITH YOPJ, AND ACETYLATION.
DOI=10.1126/science.1126867; PubMed=16728640 [NCBI, ExPASy, EBI, Israel, Japan]
Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J., Orth K.;
"Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation.";
Science 312:1211-1214(2006).
[9]
IDENTIFICATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
Colinge J., Superti-Furga G., Bennett K.L.;
Submitted (OCT-2008) to UniProtKB.
[10]
VARIANTS COLON CANCER TRP-175 AND VAL-215.
DOI=10.1006/geno.2001.6551; PubMed=11414763 [NCBI, ExPASy, EBI, Israel, Japan]
Teng D.-H., Chen Y., Lian L., Ha P.C., Tavtigian S.V., Wong A.K.C.;
"Mutation analyses of 268 candidate genes in human tumor cell lines.";
Genomics 74:352-364(2001).
[11]
VARIANTS [LARGE SCALE ANALYSIS] THR-26; PRO-68; THR-84; ILE-90; LEU-94; TRP-96; HIS-293 AND MET-339.
DOI=10.1038/nature05610; PubMed=17344846 [NCBI, ExPASy, EBI, Israel, Japan]
Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
"Patterns of somatic mutation in human cancer genomes.";
Nature 446:153-158(2007).
Comments
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
L36719; AAC41718.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
D87116; BAA13248.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U66839; AAB40652.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U66840; AAB40653.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AK093838; BAG52769.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC032478; AAH32478.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00218857; -.
IPI00218858; -.
IPI00220438; -.
RefSeq NP_002747.2; -.
NP_659731.1; -.
UniGene Hs.514012
3D structure databases
ModBase P46734.
Protein-protein interaction databases
IntAct P46734; 2.
PTM databases
PhosphoSite P46734; -.
Enzyme and pathway databases
BRENDA 2.7.12.2; 247.
Pathway_Interaction_DB anthraxpathway; Cellular roles of Anthrax toxin.
il12_2pathway; IL12-mediated signaling events.
p38_mkk3_6pathway; p38 MAPK signaling pathway.
p38alphabetapathway; Regulation of p38-alpha and p38-beta.
vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
p38gammadeltapathway; Signaling mediated by p38-gamma and p38-delta.
tnfpathway; TNF receptor signaling pathway.
mapktrkpathway; Trk receptor signaling mediated by the MAPK pathway.
Organism-specific databases
GeneCards GC17P021128; -.
GC17P021129; -.
H-InvDB HIX0013631; -.
HGNC HGNC:6843; MAP2K3.
GenAtlas MAP2K3.
HPA CAB018548; -.
MIM 602315; gene. [NCBI / EBI]
PharmGKB PA30588; -.
Gene expression databases
ArrayExpress P46734; -.
Bgee P46734; -.
CleanEx HS_MAP2K3; -.
GermOnline ENSG00000034152; Homo sapiens.
Ontologies
GO
GO:0005524; Molecular function: ATP binding (inferred from electronic annotation from UniProtKB-KW).
GO:0004708; Molecular function: MAP kinase kinase activity (traceable author statement from ProtInc).
GO:0005515; Molecular function: protein binding (inferred from physical interaction from UniProtKB).
GO:0004674; Molecular function: protein serine/threonine kinase activity (inferred from electronic annotation from UniProtKB-KW).
GO:0004713; Molecular function: protein tyrosine kinase activity (inferred from electronic annotation from UniProtKB-KW).
GO:0045893; Biological process: positive regulation of transcription, DNA-dependent (inferred from direct assay from UniProtKB).
QuickGo view.
Family and domain databases
InterPro IPR000719; Prot_kinase_core.
IPR017441; Protein_kinase_ATP_BS.
IPR017442; Se/Thr_pkinase-rel.
IPR008271; Ser_thr_pkin_AS.
IPR002290; Ser_thr_pkinase.
Graphical view of domain structure.
Pfam PF00069; Pkinase; 1.
Pfam graphical view of domain structure.
ProDom PD000001; Prot_kinase; 1.
[Domain structure / List of seq. sharing at least 1 domain]
SMART SM00220; S_TKc; 1.
SMART graphical view of domain structure.
PROSITE PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00108; PROTEIN_KINASE_ST; 1.
PROSITE graphical view of domain structure (profiles).
Proteomic databases
PRIDE P46734; -.
Genome annotation databases
Ensembl ENSG00000034152; Homo sapiens. [Contig view]
GeneID 5606; -.
KEGG hsa:5606; -.
Phylogenomic databases
HOVERGEN P46734; -.
Other
NextBio 21784; -.
PMAP-CutDB P46734; -.
SOURCE MAP2K3; Homo sapiens.
ProtoNet P46734.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
Acetylation; Alternative splicing; ATP-binding; Disease mutation; Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism; Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
CHAIN   1   347  347     Dual specificity mitogen-activated protein kinase kinase 3. PRO_0000086378
DOMAIN   64   325  262     Protein kinase. 
NP_BIND   70    78  9     ATP (By similarity). 
ACT_SITE   190   190        Proton acceptor (By similarity). 
BINDING   93    93        ATP (By similarity). 
MOD_RES   218   218        Phosphoserine. 
MOD_RES   222   222        Phosphothreonine. 
VAR_SEQ   1    29        Missing (in isoform 1). VSP_004878
VAR_SEQ   1    16        MESPASSQPASMPQSK -> MGVQGTLMSRDSQTPHLLSIL (in isoform 2). VSP_004877
VARIANT   26    26  1     R -> T. VAR_040817 
VARIANT   40    40  1     P -> T (in dbSNP:rs33911218 [NCBI]). VAR_046062 
VARIANT   68    68  1     S -> P (in dbSNP:rs34105301 [NCBI]). VAR_046063 
VARIANT   84    84  1     A -> T (in dbSNP:rs2305873 [NCBI]). VAR_046064 
VARIANT   90    90  1     M -> I (in dbSNP:rs36076766 [NCBI]). VAR_046065 
VARIANT   94    94  1     R -> L (in dbSNP:rs56067280 [NCBI]). VAR_046066 
VARIANT   96    96  1     R -> W (in dbSNP:rs56216806 [NCBI]). VAR_046067 
VARIANT   175   175  1     R -> W (in colon cancer). VAR_014208 
VARIANT   215   215  1     L -> V (in colon cancer). VAR_014209 
VARIANT   293   293  1     R -> H (in dbSNP:rs35206134 [NCBI]). VAR_046068 
VARIANT   339   339  1     V -> M. VAR_046069 
MUTAGEN   218   218        S->A: Inactivation. 
MUTAGEN   218   218        S->E: Constitutive activation. 
MUTAGEN   222   222        T->A: Inactivation. 
MUTAGEN   222   222        T->E: Constitutive activation. 
CONFLICT   341   341        E -> K (in Ref. 1 and 3). 
Sequence information
Length: 347 AA [This is the length of the unprocessed precursor] Molecular weight: 39318 Da [This is the MW of the unprocessed precursor] CRC64: A80BA4FDFF8F75A2 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MESPASSQPA SMPQSKGKSK RKKDLRISCM SKPPAPNPTP PRNLDSRTFI TIGDRNFEVE 

        70         80         90        100        110        120 
ADDLVTISEL GRGAYGVVEK VRHAQSGTIM AVKRIRATVN SQEQKRLLMD LDINMRTVDC 

       130        140        150        160        170        180 
FYTVTFYGAL FREGDVWICM ELMDTSLDKF YRKVLDKNMT IPEDILGEIA VSIVRALEHL 

       190        200        210        220        230        240 
HSKLSVIHRD VKPSNVLINK EGHVKMCDFG ISGYLVDSVA KTMDAGCKPY MAPERINPEL 

       250        260        270        280        290        300 
NQKGYNVKSD VWSLGITMIE MAILRFPYES WGTPFQQLKQ VVEEPSPQLP ADRFSPEFVD 

       310        320        330        340 
FTAQCLRKNP AERMSYLELM EHPFFTLHKT KKTDIAAFVK EILGEDS 

P46734 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!